Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Original Article

AJVS. 2021; 70(2): 15-28

Using Lactobacillus Acidophilus in Fish Feed to Improve Disease Resistance and Immune Status of Cultured Nile Tilapia

Heba, Mohamed Mousa, . Abeer Mohamed El-Keredy, Mohamed Adel Rashed.

The probiotic activity of Lactobacillus acidophilus bacteria as a dietary supplement was estimated by its effect on the immune response of Nile tilapia (Oreochromis niloticus) and its protective effect against challenge infections The present study predestined the effects of different Lactobacillus acidophilus dietary levels as feed supplement on growth performance, biochemical parameters, antioxidant activity and protection of Oreochromis niloticus against Enterococcus faecalis that previously isolated from cultured Oreochromis niloticus from Kafr Elsheikh Governorate fish farms that identified by biochemical tests and API20 E .Six types of bacteria were found, Enterococcus faecalis by 25%, Aeromonas hydrophilla by 20.9%, Pseudomonas.auriginousa. by 18.6% Staphylococcus aureus20..9%., Escherichia coli by11.6% and proteus vulgaris by 2.3% were isolated from 60 apparently healthy and naturally infected Oreochromis niloticus fish collected from Kafr El Sheikh Governorate fish farms . Fish were allotted into 5 groups, 1st and 2nd group fed on basal diet and 3rd ,4th and 5th fed on basal diet supplemented by different levels of dietary Lactobacillus acidophilus 1.5 × 108, 3 × 108 and 6 × 108 CFU /g respectively for 10 weeks. Our results showed that dietary administration of different levels of L. acidophilus improved weight gain rate, relative growth rate, average body weight and feed conversion ratio compared to fish fed unsupplemented diet. Also showed the superior results in biochemical parameters (significant increase (P < 0.05) in lysosomal activity, bactericidal activity, WBCs, antioxidant enzymes activities and significant decrease (P < 0.05) in cholesterol, cortisol and glucose and the appropriate inclusion is 6 × 108 CFU /g. It could be concluded that using Lactobacillus acidophilus good due to their high effective growth promoting, antibacterial and positive impact on innate immunity and antioxidant enzymes activities and had hypocholesteremic and hypoglycemic effect. This study highly recommends the use of Lactobacillus acidophilus as therapeutic agents in dealing with Enterococcus faecalis infection in fish culture. On our study Lactobacillus acidophilus can act as probiotics to improve immune responses ,growth, and fish welfare.

Key words: : Lactobacillus Acidophillus, growth performance, immune status, disease resistance, Nile Tilapia. : Lactobacillus Acidophillus, growth performance, immune status, disease resistance, Nile Tilapia.

Similar Articles

Exploring the Alzheimer's disease neuroepigenome: recent advances and future trends.
Zhang H, Elefant F
Neural regeneration research. 2022; 17(2): 325-327

MTA1, a metastasis‑associated protein, in endothelial cells is an essential molecule for angiogenesis.
Ishikawa M, Osaki M, Uno N, Ohira T, Kugoh H, Okada F
Molecular medicine reports. 2022; 25(1):

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson's disease.
Goulding SR, Anantha J, Collins LM, Sullivan AM, O'Keeffe GW
Neural regeneration research. 2022; 17(1): 38-44

Differentiating Human Pluripotent Stem Cells to Vascular Endothelial Cells for Regenerative Medicine, Tissue Engineering, and Disease Modeling.
Bertucci T, Kakarla S, Kim D, Dai G
Methods in molecular biology (Clifton, N.J.). 2022; 2375(): 1-12

Presenilin mutations and their impact on neuronal differentiation in Alzheimer's disease.
Hernandez-Sapiens MA, Reza-Zaldívar EE, Márquez-Aguirre AL, Gómez-Pinedo U, Matias-Guiu J, Cevallos RR, Mateos-Díaz JC, Sánchez-González VJ, Canales-Aguirre AA
Neural regeneration research. 2022; 17(1): 31-37

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Covid-19 Trends and Statistics
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.

ScopeMed Web Sites